Postherpetic Neuralgia Market is driven by rising herpes zoster prevalence
Postherpetic neuralgia (PHN) represents a chronic neuropathic pain condition that persists after the resolution of herpes zoster (shingles) lesions. PHN management typically involves antiviral agents, analgesics, topical therapies, anticonvulsants, and antidepressants, each offering distinct mechanisms to mitigate nerve damage–related pain. The advantages of these products include...
0 التعليقات 0 المشاركات 40 مشاهدة 0 معاينة